Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump

Journal of Diabetes Science and Technology

Volumn 3, Issue 6, 2009, Pages 1402-1410

  Rubin, Richard R ^a   Peyrot, Mark ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY MARYLAND   (United States)

Author keywords

Continuous glucose monitoring; Continuous subcutaneous insulin infusion; Health related quality of life; Patient satisfaction

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG EFFECT; ECONOMICS; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; HUMAN; INFUSION PUMP; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INTERNET; MALE; METABOLISM; MIDDLE AGED; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PREDICTION AND FORECASTING; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC EQUIPMENT; EQUIPMENT DESIGN; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; INTERNET; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956579119     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300621     Document Type: Article

References (21)

1. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008;10(5):377-83.
2. Reach G. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther. 2008;10(2):69-80. (Pubitemid 351230288)
3. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50. (Pubitemid 44033429)
4. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther. 2004;6(2):105-13. (Pubitemid 38445735)
5. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2002;324(7339):705.
6. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25(7):765-74.
7. Bruttomesso D, Pianta A, Crazzolara D, Scaldaferri E, Lora L, Guarneri G, Mongillo A, Gennaro R, Miola M, Moretti M, Confortin L, Beltramello GP, Pais M, Baritusssio A, Casiglia E, Tiengo A. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability, and quality of life. Diabet Med. 2002;19(8):628-34. (Pubitemid 34985162)
8. Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, Fradin S, Reznik Y. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39(3):224-9. (Pubitemid 46580623)
9. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ, Dutch Insulin Pump Study Group. A randomized trial of continuous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care. 2002;25(11):2074-80.
10. Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 2005;28(7):1568-73. (Pubitemid 40923066)
11. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care. 2003;26(9):2598-603. (Pubitemid 37052106)
12. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-76.
13. Peyrot M, Rubin RR. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system. Diabetes Technol Ther. 2009;11(1):57-62.
14. Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care. 2005;28(1):53-8. (Pubitemid 40095782)
15. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-92.
16. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1969.
17. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K, Diabetes Research in Children Network (DirecNet) Study Group. Freestyle Navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care. 2008;31(3):525-7.
18. Diabetes Research in Children (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care. 2005;28(8):1929-35.
19. Bradley C. Designing medical and educational intervention studies. A review of some alternatives to conventional randomized controlled trials. Diabetes Care. 1993;16(2):509-18. (Pubitemid 23046645)
20. Rubin RR, Peyrot M. Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy. Curr Med Res Opin. 2007;23(8):1919-29. (Pubitemid 47300391)
21. Peyrot M, Rubin RR. How does treatment satisfaction work? Modelling determinants of treatment satisfaction and preference. Diabetes Care. 2009; 32(8):1411-7.